“Cysteamine: Clinical Efficacy, Safety and Tolerability Versus Best-in-Class Treatments for Melasma ”. 2021. SKIN The Journal of Cutaneous Medicine 5 (6): s88. https://doi.org/10.25251/skin.5.supp.88.